ANGIODYNAMICS INC Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Angiodynamics Inc quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q3 2020 to Q3 2024.
  • Angiodynamics Inc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending August 31, 2024 was $67.5M, a 14.2% decline year-over-year.
  • Angiodynamics Inc Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending August 31, 2024 was $293M, a 12.9% decline year-over-year.
  • Angiodynamics Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $304M, a 10.3% decline from 2022.
  • Angiodynamics Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $339M, a 7.13% increase from 2021.
  • Angiodynamics Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $316M, a 8.66% increase from 2020.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $293M $67.5M -$11.2M -14.2% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-03
Q2 2024 $304M $71M -$20.1M -22.1% Mar 1, 2024 May 31, 2024 10-K 2024-07-25
Q1 2024 $324M $75.2M -$5.53M -6.85% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-09
Q4 2023 $330M $79.1M -$6.36M -7.44% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-08
Q3 2023 $336M $78.7M -$2.86M -3.51% Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-03
Q2 2023 $339M $91.1M +$4.08M +4.69% Mar 1, 2023 May 31, 2023 10-K 2024-07-25
Q1 2023 $335M $80.7M +$6.74M +9.12% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-09
Q4 2022 $328M $85.4M +$7.15M +9.13% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-08
Q3 2022 $321M $81.5M +$4.57M +5.93% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-05
Q2 2022 $316M $87M +$10.2M +13.2% Mar 1, 2022 May 31, 2022 10-K 2024-07-25
Q1 2022 $306M $74M +$2.79M +3.92% Dec 1, 2021 Feb 28, 2022 10-Q 2023-03-31
Q4 2021 $303M $78.3M +$5.51M +7.57% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-06
Q3 2021 $298M $77M +$6.76M +9.62% Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-11
Q2 2021 $291M $76.8M Mar 1, 2021 May 31, 2021 10-K 2023-08-03
Q1 2021 $71.2M Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-07
Q4 2020 $72.8M Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-07
Q3 2020 $70.2M Jun 1, 2020 Aug 31, 2020 10-Q 2021-09-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.